U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX8485008: GSM4593924: bi26lacmid_A; Bifidobacterium longum subsp. infantis; RNA-Seq
1 ILLUMINA (Illumina HiSeq 2500) run: 15.2M spots, 4.6G bases, 1.7Gb downloads

Submitted by: NCBI (GEO)
Study: Strain-Specific Strategies of Human Milk Oligosaccharide 2'-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose Assimilation by Bifidobacterium longum subsp. infantis Strains Bi-26 and ATCC 15697
show Abstracthide Abstract
Human milk oligosaccharides (HMOs) function as prebiotics for beneficial bacteria in the developing gut, often dominated by Bifidobacterium spp. To understand the relationship between Bifidobacterium utilizing HMOs and how the metabolites that are produced could affect the host, we analyzed the metabolism of HMO 2'-fucosyllactose (2'-FL), 3-fucosyllactose (3FL and difucosyllactose (DFL) in Bifidobacterium longum ssp. infantis Bi-26 and ATCC15697. RNA-seq and metabolite analysis was performed on samples at early (A600=0.25), mid-log (0.5-0.7) and late-log phases (1.0-2.0) of growth. Overall design: Bifidobacterium longum subsp. infantis strain Bi-26 and ATCC15697 was used in this study with 2'-FL, 3FL and DFL as the test carbon sources and lactose or no carbohytdrate added control, Samples were done in duplicate with samples taken at early phase (A600 ~0.2) mid log (0.5-1.1) and late log (1.1+). ATCC15697 only had mid-log samples taken.
Sample: bi26lacmid_A
SAMN15154013 • SRS6785029 • All experiments • All runs
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: After each sample reached its desired A600 range, cells were centrifuged for 10 min. at 4,063 x g. The supernatant was removed and 1 mL of TRIzol (p/n: 15596026, Thermo) was added. The pellet was re-suspended by vortexing and the tubes were immediately frozen at -80°C. The cell pellets were later thawed, transferred to a Lysing Matrix B 2mL tube (p/n: 116911050, MPBio, Santa Ana, CA), and disrupted using a Mini-Beadbeater. The lysate was subjected to a chloroform organic extraction and followed by purification using RNeasy Mini Kit (p/n: 74104, Qiagen, Hilden, Germany). Quality checks and quantifications of the isolated RNA were carried out on the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Ribosomal RNA was removed prior to library construction using Ribo-Zero rRNA Removal Kit Gram-Positive Bacteria (p/n: MRZGP126, Illumina). Stranded cDNA libraries were prepared using TruSeq Stranded mRNA Kit (p/n: 20020594, Illumina), quantitated by Agilent TapeStation, pooled quimolarly, and sequenced on one flowcell lane for 75 cycles using paired-end 75 basepair sequencing on Illumina 2500 HiSeq Rapid Cluster Kit v. 2 (p/n: PE-402-4002, Illumina) and HiSeq Rapid SBS Kit v. 2 (p/n: FC-402-4021, Illumina).
Experiment attributes:
GEO Accession: GSM4593924
Links:
Runs: 1 run, 15.2M spots, 4.6G bases, 1.7Gb
Run# of Spots# of BasesSizePublished
SRR1194050915,192,7424.6G1.7Gb2020-06-07

ID:
11027387

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...